Azenta, Inc. (AZTA)

Market Cap	1.53B
Revenue (ttm)	669.17M
Net Income (ttm)	-65.36M
Shares Out	45.78M
EPS (ttm)	-1.36
PE Ratio	n/a
Forward PE	48.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	557,201
Open	32.67
Previous Close	31.43
Day's Range	32.67 - 33.56
52-Week Range	23.91 - 63.58
Beta	1.64
Analysts	Buy
Price Target	45.00 (+34.25%)
Earnings Date	Aug 5, 2025

About AZTA

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Feb 1, 1995
• Employees: 3,300
• Stock Exchange: NASDAQ
• Ticker Symbol: AZTA
• Website: https://www.azenta.com

Financial Performance

In 2024, Azenta's revenue was $656.32 million, a decrease of -1.32% compared to the previous year's $665.07 million. Losses were -$164.17 million, 1051.5% more than in 2023.

Analyst Summary

According to 3 analysts, the average rating for AZTA stock is "Buy." The 12-month stock price target is $45.0, which is an increase of 34.25% from the latest price.

Price Target

$45.0

(34.25% upside)

Analyst Consensus: Buy